What Is Selank?
Selank is a synthetic heptapeptide and a short-chain oligopeptide compound. Published research describes Selank as a synthetic analogue of the endogenous peptide tuftsin, placing it within the broader class of tuftsin-derived peptide compounds.
Selank has a defined seven residue peptide structure and is recognized chemically as an oligopeptide. Its structure incorporates the tuftsin sequence with an additional three-residue extension, distinguishing Selank from the shorter endogenous peptide.
Research Overview Table
Chemical and Molecular Characteristics
Selank is a synthetic oligopeptide with a defined seven-residue architecture and a linear peptide backbone. Its structure contains multiple proline residues together with basic amino acid residues, giving the molecule a combination of conformational constraint and polar functional groups. Reports high polarity and low predicted lipophilicity for the compound.
The peptide structure differs from small nonpeptide research compounds through its linked amino acid residues and stereochemically defined backbone. Published research also describes Selank as a distinct synthetic heptapeptide rather than a larger protein or polypeptide. These structural characteristics determine its physicochemical behavior and provide the basis for its chemical classification.
Certificates:
Mechanism of Action Under Investigation
Published studies identify GABAergic signaling as one proposed molecular mechanism of Selank. Receptor-binding experiments found that Selank altered GABA binding in a concentration dependent manner, with findings consistent with positive allosteric modulation of GABA receptors. The studies suggested subtype-selective activity, although the specific receptor subtype and binding site have not been conclusively established.
A separate group of studies investigated Selank's interaction with enkephalin-degrading enzymes. Selank inhibited the enzymatic hydrolysis of enkephalins in human serum and plasma. Further experimental work found greater inhibitory activity toward carboxypeptidases and dicarboxypeptidases. These findings indicate that inhibition of enkephalin degradation is another proposed component of Selank's molecular activity.
The available studies therefore support GABA receptor modulation and inhibition of enkephalin-degrading enzymes as mechanisms under investigation. However, the published evidence does not establish one definitive molecular target or fully explain how these mechanisms are related.
Scientific Research Context
Selank appears in the scientific literature as an experimental peptide for studying neurobiological processes. Investigators have examined its biological activity in cellular systems, brain-related experimental settings and animal models, including research involving neurotransmitter regulation and gene expression. The available findings come primarily from in vitro and preclinical animal models.
Selank Biology and Biological Pathways
Primary Biological Function
Published studies investigate Selank within neurobiological regulation, particularly neurotransmitter-related processes in the brain. Research has examined GABAergic gene expression, brain monoamines and their metabolites and BDNF levels in specific neural regions. These findings provide biological measures for studying selank associated changes in neuronal signaling and brain biochemical regulation.
Relevant Signaling Pathways
Published evidence places Selank research mainly within GABAergic and monoaminergic signaling. GABAergic pathways involve receptor subunits, transporters and ion channels that regulate neuronal inhibition and communication. Monoaminergic pathways include serotonin, dopamine and norepinephrine systems involved in neural signaling and regulation. Research has also examined genes associated with these systems, providing a basis for investigating their biological relationship with Selank.
Tissue-Specific Biology
Selank research has examined several regions of the central nervous system with distinct biological roles. The hippocampus and prefrontal cortex have been studied in relation to BDNF expression and content. The hippocampus, hypothalamus, striatum, and frontal cortex have also been examined for regional monoamine and metabolite measurements. These findings indicate that the biological parameters investigated with Selank differ according to the neural tissue examined.
Experimental Biomarkers
Published studies have measured several biological markers to characterize Selank-associated changes. These include GABA-related gene expression, dopamine, serotonin, norepinephrine and their metabolites. BDNF content has also been measured in the hippocampus and frontal cortex. Gene-expression studies have examined multiple neurotransmission-related genes, including GABA receptor subunits, transporters, ion channels, and dopamine and serotonin receptors.
Laboratory Investigation Methods
Researchers have investigated these biological systems using quantitative real-time PCR, neurotransmitter and metabolite measurements, ex vivo brain-tissue analysis, and receptor-binding experiments. Real-time PCR has been used to examine neurotransmission-related gene expression in rat frontal cortex and cultured human neuroblastoma cells. Other studies have measured monoamines and metabolites in discrete brain regions and assessed BDNF in brain tissue.
Experimental Models Used in Published Research
Selank has been investigated using cell-based systems and several animal models, with most published work relying on rodents. The models differ in biological complexity and relevance. Their limitations mainly concern the restricted representation of whole-organism biology in cellular systems and the differences between laboratory animals and human physiology.
Cell-Based Models
Cultured human peripheral blood cells have been used as an in vitro model in Selank research. This approach permits cellular responses to be examined under controlled conditions. Its main limitation is that isolated cells cannot reproduce the interactions among tissues, organs and systemic biological processes present in an intact organism.
Rat Models
Wistar and WAG/Rij rats are documented experimental models in Selank research. Wistar rats are used as an outbred laboratory strain, while WAG/Rij rats provide a genetically defined model with distinct neurobiological characteristics. The main limitations are strain-specific differences and physiological differences between rats and humans, which restrict direct translation of findings across species.
Mouse Models
Mice, including BALB/c and C57BL/6 strains, have also been used in Selank research. Different strains permit investigation across genetically distinct backgrounds. However, strain-dependent characteristics can influence experimental responses. Differences between mouse and human neurobiology limit direct translation beyond the animal model.
Ex Vivo Brain-Tissue Preparations
Ex vivo brain-tissue preparations have been used alongside in vivo animal experiments, including analyses of hippocampal and frontal cortical tissue. These preparations allow biological characteristics of defined neural tissues to be examined outside the intact organism. Their limitation is the loss of normal systemic and whole-brain interactions.
Selank Published Research
GABAergic Neurotransmission
Researchers have investigated Selank in relation to GABAergic neurotransmission, including genes associated with GABA receptors, transporters, and ion channels. Related work has examined broader neurotransmission-related gene expression.
Monoamine Regulation
Another area of investigation involves monoamine regulation, including serotonin, dopamine, norepinephrine, and their metabolites in different brain regions.
Learning and Memory
Selank has been investigated in learning and memory processes, including conditioned learning, memory retention, and cognitive performance in experimental research.
BDNF Biology
Researchers have also examined Selank in relation to brain-derived neurotrophic factor (BDNF), including BDNF content in the hippocampus and prefrontal cortex.
Enkephalin Metabolism
Selank has been investigated in relation to enkephalin degradation, particularly the enzymatic breakdown of Leu-enkephalin in human plasma and serum. Researchers have examined the activity of enkephalin-degrading peptidases and Selank's interaction with these enzymes.
Limitations of Current Research
Evidence Is Predominantly Preclinical
The Selank literature is still weighted toward experimental research. Human clinical studies are present, but they represent a much smaller portion of the available literature. This imbalance limits the strength of conclusions that can be drawn from the overall evidence base.
Human Clinical Evidence
The available clinical evidence is limited in scale. One randomized study included 62 patients, while another comparative clinical study included 60 patients. These studies provide human data, but the relatively small clinical literature does not establish whether the reported observations are consistent across wider populations.
Species Differences
Much of the published evidence concerns biological processes that can differ between species. Consequently, observations reported in preclinical research cannot be assumed to reflect human biology in the same way. Human studies are needed to determine how consistently findings observed outside humans apply to people.
Study Design Limitations
The clinical literature includes comparative studies with relatively small participant groups and different comparators and outcome measures. For example, one study compared Selank with medazepam, while another compared Selank with phenazepam. These differences make the findings less suitable for direct comparison across studies.
Independent Replication
The available PubMed literature does not provide a strong body of independent replication for the major findings reported with Selank. Several areas have been examined repeatedly, but confirmation by separate research groups using comparable study designs remains limited. This leaves uncertainty about the reproducibility of individual observations.
Long-Term Evidence
Long-term clinical evidence remains limited. The published human studies identified in the literature involve relatively short treatment periods rather than extended follow-up. As a result, the available evidence provides little information about outcomes associated with prolonged exposure or longer-term biological changes.
Analytical Documentation
HPLC is used in published Selank work for peptide purification and purity assessment. LC-MS/MS has also been applied to identify Selank in analyzed preparations.
NMR may provide additional structural information for peptide characterization, but I did not find a Selank-specific PubMed study establishing it as a routine analytical test. A Certificate of Analysis (CoA) can record batch-specific identity and purity results for laboratory material.
Analytical documentation helps establish that the material matches its stated identity and quality specifications. It verifies product identity and quality rather than biological performance.
Storage and Laboratory Handling
The Certificate of Analysis lists 2–8°C as the storage condition. Storage should be maintained within this range and in accordance with the product specifications to help protect the material from unsuitable conditions.
Qualified personnel should handle the material in the laboratory using appropriate laboratory practices. Care should be taken to prevent contamination during handling and storage. The material is intended for laboratory research use only.
Frequently asked questions
Why choose us?
Direct SARMs Slovenia is an established supplier of research peptides. We are committed to product quality, reliable service, and helpful customer support.
Our European-made products undergo rigorous purity testing, with clear product information provided for each research material. We also aim to provide dependable shipping and a smooth ordering experience.
Our support team is available to assist with orders, shipping, payments, and general questions. At Direct SARMs Slovenia, we aim to make the research supply process simple, clear, and reliable.